Results 321 to 330 of about 218,065 (393)
Some of the next articles are maybe not open access.
Platelet aggregation inhibitors in neurology
Pharmacy World & Science, 1993This literature review reports on secondary prevention of ischaemic stroke. The aim of secondary prevention is to protect patients who belong to a risk group from the occurrence of brain infarction. Symptomatic patients with a demonstrated carotid artery stenosis of 70% and more will most probably benefit from carotid endarterectomy if performed by a ...
A. Keyser
semanticscholar +4 more sources
Prostaglandins as Inhibitors of Human Platelet Aggregation
British Journal of Haematology, 1979Summary. The potencies of prostaglandins (PG) I2, PGD2 and PGE1 as inhibitors of human platelet aggregation induced by threshold concentrations of four aggregating agents were determined in platelet‐rich plasma from normal individuals who had not ingested aspirin. The order of activity against ADP, adrenaline and collagen was always PGI2 > PGD2 >
G. Minno, M. Silver, G. Gaetano
semanticscholar +5 more sources
Platelet Aggregation Inhibition with Glycoprotein IIb–IIIa Inhibitors
Journal of Thrombosis and Thrombolysis, 2001Inhibitors of the platelet receptor glycoprotein (GP) IIb--IIIa are a novel and potent class of antithrombotic drugs for the management of patients with non-ST-segment elevation acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI).
G. Proimos
semanticscholar +4 more sources
Disposition of anagrelide, an inhibitor of platelet aggregation
Clinical Pharmacology and Therapeutics, 1981A single dose of 14C-anagrelide (6,7-dichloro-1,5-dihydroimidazo [2,1-b] quinazoline-2(3H)-one monohydrochloride) equivalent to 1 mg free base and containing 100 muCi radioactivity, was taken by five healthy, fasting men. Blood, plasma, urine, and feces were analyzed for total radioactivity. Plasma and urine concentrations of anagrelide were determined,
Kenneth A. Pittman +3 more
openaire +3 more sources
Inhibitors of platelet aggregation from onion
Phytochemistry, 1990Abstract Five new sulphur-containing compounds and five diastereoisomers which indicated potent inhibitory efrects for collagen-induced aggregation of human platelets in vitro as well as ADP- or arachidonate-induced aggregation were isolated from onion. All isolated compounds have a 1-(methylsulphinyl)-propyl alkyl (or alkenyl) disulphide skeleton.
Yasujiro Morimitsu, Shunro Kawakishi
openaire +2 more sources
Hypopigmentation in Dogs Treated with an Inhibitor of Platelet Aggregation
Toxicologic Pathology, 1989Hypopigmentation was the principal manifestation of systemic toxicity when the experimental platelet aggregation inhibitor, PD-89454, was orally administered to Beagle dogs for 28 days. Pigmentation changes were present in skin of nose, lips and eyelids and mucosa of hard palate.
Alexander W. Gough, Kathleen M. Walsh
openaire +3 more sources
Inhibitors of “spontaneous” platelet aggregation in whole blood
Atherosclerosis, 1985In vitro 'spontaneous' platelet aggregation has been studied in whole blood. The spectrum of activity of materials known to influence platelet aggregation in platelet-rich plasma proved different in whole blood. Thus dipyridamole and one of its analogues SH1242 had a striking effect in whole blood whilst aspirin, chlorpromazine and K3920 had little or ...
E. Weisblatt +3 more
openaire +3 more sources
In Vitro Evaluation of Inhibitors of Platelet Release and Aggregation
Archives of Surgery, 1975In order to determine which drugs would be most effective as inhibitors of platelet release and aggregation, in vitro release reactions and platelet aggregometry were used to evaluate aspirin, dipyridamole, sulfinpyrazone, flurbiprofen, low molecular weight dextran (dextran 40), prostaglandin E1 (PGE1), apyrase, and adenosine.
J. C. Rosenberg, Thomas L. Sell
openaire +3 more sources